Refine by
Disease Progression Suppliers & Manufacturers
115 companies found
based inSyracuse, NEW YORK (USA)
Mesothelioma is an aggressive cancer that affects the lining of the lungs, heart, or abdomen. Caused by the inhalation of asbestos fibers, mesothelioma is often diagnosed in older individuals who worked with asbestos products. Prognosis for ...
based inNew York, NEW YORK (USA)
On a mission to unlock the power of data to improve health. Transactional health data has long been the foundation of healthcare analytics. But alone, it has serious analytical limitations — on prognoses, trials, outcomes, and commercial education. ...
Generate powerful outcomes insights from closed medical and pharmacy claims integrated with harmonized lab data.Empower outcomes studies with a full view of patient activity including lab results. Outcomes research is used by life science ...
based inSevilla, SPAIN
Biomedal S.L. is a biotechnology company which develops and supplies analytical laboratory services and innovative products for the control of disease progressions. Biomedal has more than 1000 sqm of facilities equipped with the best technology for ...
based inVirum, DENMARK
Immudex was created in 2009 when it spun off from the diagnostic company Dako, now Agilent. Since then, Immudex has grown in numbers, employees, patents, product lines, partnerships, and customers served. Research, development, and commercial ...
based inRiverside, CALIFORNIA (USA)
Therapeutics has looked at Alzheimer's disease with new eyes. We have assembled an amazing team of dedicated professionals who are focused on curing Alzheimer’s disease. This mission-oriented team discovered a major trigger for Alzheimer’s disease ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Binimetinib (MEK162) is an oral and selective MEK1/2 inhibitor. Binimetinib (MEK162) inhibits MEK with an IC50 of 12 ...
based inLa Ciotat, FRANCE
At Olea Medical, one overriding value rises above all others: preserve live. Our mission is to create innovative imaging solutions that serve human beings by delivering improved diagnostic information for better patient care. Olea Medical has built ...
Our breakthrough neuroimaging tools seamlessly integrate into your daily clinical CT & MRI workflows to assist you in every step of your decision-making in pre- and post-treatment ...
based inSan Jose, CALIFORNIA (USA)
LimFlow was founded with the deep belief that more could be done for the millions of patients worldwide suffering from the most severe form of peripheral artery disease — Chronic Limb-Threatening Ischemia (CLTI) — and who are facing the prospect of ...
Living with Peripheral Artery Disease (PAD) that progresses to CLTI is challenging. Life revolves around chronic leg pain that can become unbearable over time. The end stage of the disease is ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...
based inPaddington, AUSTRALIA
Regeneus is an Australian biotechnology company aiming to improve the quality of life of the hundreds of millions of patients worldwide suffering from long and short term pain. Pain and inflammation are responsible for a series of events leading to ...
Regeneus manufactures MSC’s under strict quality standards. In accordance with the guidelines set by the International Society for Cellular Therapy (ISCT) and our rigorous testing we are easily able to identify MSC donor ...
based inCottesloe, AUSTRALIA
Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...
Multiple indications with unmet medical need. “Our company goal is to create new products that reach their target in the brain and act as a protector against nerve cells injury. Currently, there are no approved drugs that can slow down or halt ...
based inRochester, MINNESOTA (USA)
Resoundant, Inc. is a medical technology company founded by Mayo Foundation for Medical Education and Research and is located in Rochester, MN. Resoundant is dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance ...
Resoundant offers Core Lab services in collaboration with the Mayo Clinic scientists and medical professionals who invented MR Elastography over 20 years ago. Today, Resoundant and Mayo Clinic continue to support the ongoing advancement of MRE ...
based inBubendorf, SWITZERLAND
CIS Pharma is an innovator in the life science industry in the field of Oncology and Ophthalmolog. We were awarded with the European Frost & Sullivan Technology Innovation Award for our unique smart polymer technologyœ, says Christoph Schäfer, CEO ...
based inOxford, UNITED KINGDOM
Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM) technology uses MRI brain scan data to support ...
We can provide longitudinal patient results based on changes across baseline and time points in accordance with your clinical trial protocol. Grey matter quality changes can also be provided in brain visualisations over multiple time periods. We can ...
based inLouisville, KENTUCKY (USA)
Neuroscience researchers throughout the world have used Event Related Potential (ERP) and quantitative electroencephalograph (qEEG) methods to evaluate a wide range of cognitive disorders, including Alzheimer’s disease and concussion/mTBI. ...
By facilitating an objective evaluation of patients with cognitive disorders, COGNISION® helps neurologists and other physicians differentiate between dementia and depression, track disease progression and ...
based inNewark, CALIFORNIA (USA)
ACD - a Bio-Techne brand, shortens the path to personalized medicine and enables research, drug development and clinical applications by unlocking the power of RNA. ACD is a leader in the emerging field of molecular pathology, developing cell- and ...
ACD's Professional Assay Services group has been developing RNAscope™ biomarker assays for our biopharma partners for a decade. Our biomarker assays have contributed to important clinical trial exploratory endpoints, enabled more accurate ...
based inRegensburg, GERMANY
numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that could not be addressed by single biomarker-based ...
Common cancers with established benefit of early diagnosis but for which there are no sensitive or specific tests are prostate, bladder and liver cancer1. Expensive imaging procedures are routinely required in clinical practice for diagnosis or to ...
based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Pelabresib (CPI-0610) is an investigational selective small-molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes ...
based inParis, FRANCE
Pixium Vision, created in December 2011, is a bioelectronics and brain machine interface technology company specialized in neuromodulation application whose mission is to create a world of bionic vision for those who have lost their sight, enabling ...
Age-related macular degeneration is the leading cause of severe vision loss and legal blindness in people over the age of 65 in North America and Europe. The global impact is significant with current projected estimates for people living with AMD of ...
based inSan Diego, CALIFORNIA (USA)
In our last venture, our Executive Chairman and CEO, both board certified physicians, led a team of talented and dedicated engineers to invent MediTouch, the first cloud-based EHR with touch technology on the iPad. It simplified the way providers ...
Medical algorithms are mathematical models used to make decisions in the field of medicine. These algorithms take into account a variety of factors, including patient symptoms, medical history, and test results. They are used to support ...